ANNX (STOCKS)
Annexon, Inc. Common Stock
$5.991100
+0.141100 (+2.41%)
Prev close: $5.850000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Douglas Love
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $930.75M
- Employees
- 103
- P/E (TTM)
- -4.32
- P/B (TTM)
- 4.13
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $216.41M |
| Research and Development | $184.70M |
| Other Operating Expenses | $31.71M |
| Operating Income/Loss | -$216.41M |
| Income/Loss From Continuing Operations After Tax | -$206.69M |
| Income/Loss From Continuing Operations Before Tax | -$206.69M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$206.69M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$206.69M |
| Net Income/Loss Available To Common Stockholders, Basic | -$208.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.86M |
| Preferred Stock Dividends And Other Adjustments | $1.86M |
| Basic Earnings Per Share | -$1.34 |
| Diluted Earnings Per Share | -$1.34 |
| Basic Average Shares | 155,105,832 |
| Diluted Average Shares | 155,105,832 |
| Assets | $277.57M |
| Current Assets | $242.19M |
| Cash | $238.30M |
| Other Current Assets | $3.89M |
| Noncurrent Assets | $35.38M |
| Fixed Assets | $10.62M |
| Other Non-current Assets | $24.76M |
| Liabilities | $65.92M |
| Current Liabilities | $42.63M |
| Accounts Payable | $14.93M |
| Other Current Liabilities | $27.70M |
| Noncurrent Liabilities | $23.29M |
| Equity | $211.65M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $211.65M |
| Liabilities And Equity | $277.57M |
| Net Cash Flow From Operating Activities | -$186.36M |
| Net Cash Flow From Operating Activities, Continuing | -$186.36M |
| Net Cash Flow From Investing Activities | $190.05M |
| Net Cash Flow From Investing Activities, Continuing | $190.05M |
| Net Cash Flow From Financing Activities | $108.86M |
| Net Cash Flow From Financing Activities, Continuing | $108.86M |
| Exchange Gains/Losses | $2.00K |
| Net Cash Flow | $112.55M |
| Net Cash Flow, Continuing | $112.55M |
| Comprehensive Income/Loss | -$206.73M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$206.73M |
| Other Comprehensive Income/Loss | -$39.00K |